+44 79 19 49 39 39 wilsonblaney@gmail.com

The U.S. Food and Drug Administration (FDA) is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.
What’s New: Drugs RSS Feed

Share Button